As of 2026-04-03, 昆明梓橦宫全新生物制药有限公司's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 45.5 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 昆明梓橦宫全新生物制药有限公司's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
昆明梓橦宫全新生物制药有限公司's Mention Rate is 0.00%, lower than 0.6% of competitors
昆明梓橦宫全新生物制药有限公司's First Mention is 0.00%, lower than 0.9% of competitors
昆明梓橦宫全新生物制药有限公司's Preferred Rate is 0.00%, lower than 100.0% of competitors
昆明梓橦宫全新生物制药有限公司's Positive Rate is 0.00%, lower than 8.9% of competitors
昆明梓橦宫全新生物制药有限公司's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 71.21% | 18.18% | 36.84% | 68.18% | 6.06% | View Details |
| 中中国生物制药 | 40.91% | 0% | 0% | 34.85% | 0% | View Details |
| 云云南白药 | 24.24% | 0% | 0% | 15.15% | 1.52% | View Details |
| 北北京双鹭药业股份有限公司 | 0% | 0% | 0% | 0% | 0% | View Details |
| 摩摩熵医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 华华北制药股份有限公司 | 0% | 0% | 0% | 0% | 0% | View Details |
| 昆昆明梓橦宫全新生物制药有限公司 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
